Literature DB >> 14576141

Antifungal combinations against Candida albicans biofilms in vitro.

Stefano P Bachmann1, Gordon Ramage, Kacy VandeWalle, Thomas F Patterson, Brian L Wickes, José L López-Ribot.   

Abstract

Candida biofilms display increased resistance to most antifungal agents. We have evaluated the efficacy of combinations of fluconazole (FLC), amphotericin B, and caspofungin (CSP) against Candida albicans biofilms in vitro. Indifference was observed for all the combinations of paired antifungal agents when a checkerboard titration method was used. Time-kill experiments revealed an antagonistic effect of high FLC doses with CSP.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14576141      PMCID: PMC253764          DOI: 10.1128/AAC.47.11.3657-3659.2003

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  11 in total

Review 1.  Riddle of biofilm resistance.

Authors:  K Lewis
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

Review 2.  Candida biofilms and their susceptibility to antifungal agents.

Authors:  G S Baillie; L J Douglas
Journal:  Methods Enzymol       Date:  1999       Impact factor: 1.600

Review 3.  Biofilms of Candida albicans and their associated resistance to antifungal agents.

Authors:  G Ramage; B L Wickes; J L Lopez-Ribot
Journal:  Am Clin Lab       Date:  2001-08

4.  Antifungal resistance of candidal biofilms formed on denture acrylic in vitro.

Authors:  J Chandra; P K Mukherjee; S D Leidich; F F Faddoul; L L Hoyer; L J Douglas; M A Ghannoum
Journal:  J Dent Res       Date:  2001-03       Impact factor: 6.116

5.  Investigation of multidrug efflux pumps in relation to fluconazole resistance in Candida albicans biofilms.

Authors:  Gordon Ramage; Stefano Bachmann; Thomas F Patterson; Brian L Wickes; José L López-Ribot
Journal:  J Antimicrob Chemother       Date:  2002-06       Impact factor: 5.790

6.  Resistance of Candida albicans biofilms to antifungal agents in vitro.

Authors:  S P Hawser; L J Douglas
Journal:  Antimicrob Agents Chemother       Date:  1995-09       Impact factor: 5.191

7.  In vitro pharmacodynamic properties of three antifungal agents against preformed Candida albicans biofilms determined by time-kill studies.

Authors:  Gordon Ramage; Kacy VandeWalle; Stefano P Bachmann; Brian L Wickes; José L López-Ribot
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

8.  In vitro activity of caspofungin against Candida albicans biofilms.

Authors:  Stefano P Bachmann; Kacy VandeWalle; Gordon Ramage; Thomas F Patterson; Brian L Wickes; John R Graybill; José L López-Ribot
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

9.  Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms.

Authors:  G Ramage; K Vande Walle; B L Wickes; J L López-Ribot
Journal:  Antimicrob Agents Chemother       Date:  2001-09       Impact factor: 5.191

Review 10.  Candida biofilms and their role in infection.

Authors:  L Julia Douglas
Journal:  Trends Microbiol       Date:  2003-01       Impact factor: 17.079

View more
  36 in total

Review 1.  Candida biofilms: an update.

Authors:  Gordon Ramage; Stephen P Saville; Derek P Thomas; José L López-Ribot
Journal:  Eukaryot Cell       Date:  2005-04

2.  A 96 well microtiter plate-based method for monitoring formation and antifungal susceptibility testing of Candida albicans biofilms.

Authors:  Christopher G Pierce; Priya Uppuluri; Sushma Tummala; Jose L Lopez-Ribot
Journal:  J Vis Exp       Date:  2010-10-21       Impact factor: 1.355

3.  A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing.

Authors:  Christopher G Pierce; Priya Uppuluri; Amanda R Tristan; Floyd L Wormley; Eilidh Mowat; Gordon Ramage; Jose L Lopez-Ribot
Journal:  Nat Protoc       Date:  2008       Impact factor: 13.491

Review 4.  Synergistic combinations of antifungals and anti-virulence agents to fight against Candida albicans.

Authors:  Jinhui Cui; Biao Ren; Yaojun Tong; Huanqin Dai; Lixin Zhang
Journal:  Virulence       Date:  2015       Impact factor: 5.882

5.  Fusarium and Candida albicans biofilms on soft contact lenses: model development, influence of lens type, and susceptibility to lens care solutions.

Authors:  Yoshifumi Imamura; Jyotsna Chandra; Pranab K Mukherjee; Ali Abdul Lattif; Loretta B Szczotka-Flynn; Eric Pearlman; Jonathan H Lass; Kerry O'Donnell; Mahmoud A Ghannoum
Journal:  Antimicrob Agents Chemother       Date:  2007-11-12       Impact factor: 5.191

6.  In vitro study of sequential fluconazole and caspofungin treatment against Candida albicans biofilms.

Authors:  Semanti Sarkar; Priya Uppuluri; Christopher G Pierce; Jose L Lopez-Ribot
Journal:  Antimicrob Agents Chemother       Date:  2013-11-11       Impact factor: 5.191

7.  Candida albicans and non-C. albicans Candida species: comparison of biofilm production and metabolic activity in biofilms, and putative virulence properties of isolates from hospital environments and infections.

Authors:  A V Ferreira; C G Prado; R R Carvalho; K S T Dias; A L T Dias
Journal:  Mycopathologia       Date:  2013-03-27       Impact factor: 2.574

8.  In vitro activities of voriconazole in combination with three other antifungal agents against Candida glabrata.

Authors:  Francesco Barchiesi; Elisabetta Spreghini; Monia Maracci; Annette W Fothergill; Isabella Baldassarri; Michael G Rinaldi; Giorgio Scalise
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

9.  Biofilm formation by Pneumocystis spp.

Authors:  Melanie T Cushion; Margaret S Collins; Michael J Linke
Journal:  Eukaryot Cell       Date:  2008-09-26

10.  In vitro evaluation of antibiotic lock technique for the treatment of Candida albicans, C. glabrata, and C. tropicalis biofilms.

Authors:  Kwan Soo Ko; Ji-Young Lee; Jae-Hoon Song; Kyong Ran Peck
Journal:  J Korean Med Sci       Date:  2010-11-24       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.